Streetbeat News

Stock Prices

SNY

SPRY

The FDA has approved ARS Pharmaceuticals Inc's (NASDAQ: SPRY) Neffy nasal spray for emergency allergy treatment, providing an alternative to EpiPen and other autoinjectors like Sanofi SA's (NASDAQ: SNY) Auvi-Q. This approval comes ahead of the PDUFA target action date and is based on studies showing comparable efficacy to existing epinephrine injection products.

Portfolio Pulse from Vandana Singh

August 09, 2024 | 5:34 pm

RCAT

Red Cat Holdings shares are trading higher following the company's Q4 financial results announcement.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:34 pm

MVST

Microvast Holdings (NASDAQ:MVST) reported Q2 losses of $(0.21) per share, missing the $(0.07) estimate by 200%. Sales were $83.67M, missing the $92.35M estimate by 9.39%. Losses increased by 950% year-over-year, while sales grew by 11.64%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:32 pm

DIS

SPY

VOO

Walt Disney Co (NYSE:DIS) is experiencing a significant resurgence in 2024, driven by record-breaking box office hits like 'Inside Out 2' and 'Deadpool & Wolverine.' The company has reached $3 billion in global ticket sales with just four releases. Disney's fiscal Q3 2024 revenue grew by 4% year-on-year, beating estimates. Investors can gain exposure to Disney through SPDR S&P 500 (NYSE:SPY) and Vanguard S&P 500 ETF (NYSE:VOO).

Portfolio Pulse from Anusuya Lahiri

August 09, 2024 | 5:31 pm

HAPS

YETI

YETI Holdings, Inc. (NYSE:YETI) has been upgraded to Buy by BofA Securities with a raised price target of $55. Despite reporting strong Q2 results and raising FY24 guidance, YETI shares are down 4.26%. The company is expected to benefit from global expansion, new products, and potential M&A activities.

Portfolio Pulse from Lekha Gupta

August 09, 2024 | 5:31 pm

HD

Deep-pocketed investors have shown a bullish approach towards Home Depot (NYSE:HD) with significant options trading activity. Benzinga's options scanner highlighted 16 extraordinary options activities for Home Depot, with a mix of bullish and bearish sentiments. The major market movers are focusing on a price band between $310.0 and $560.0 for Home Depot. Analysts have mixed ratings on the stock, with price targets ranging from $360 to $400.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 5:31 pm

BMY

Deep-pocketed investors are showing a bullish sentiment towards Bristol-Myers Squibb (NYSE:BMY) through significant options activity. Benzinga's options scanner highlighted 9 extraordinary options activities, with 66% of the trades being bullish. The projected price window for BMY is between $40.0 and $50.0. Analysts have mixed ratings, with price targets ranging from $41 to $45.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 5:30 pm

AMD

Advanced Micro Devices (NASDAQ:AMD) has significantly outperformed the market over the past 5 years, delivering an average annual return of 33.21%. A $1000 investment in AMD 5 years ago would be worth $4,152.33 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 5:30 pm

GWRE

Guidewire Software (NYSE:GWRE) has outperformed the market over the past 10 years with an average annual return of 12.99%, resulting in a $1000 investment growing to $3,389.70. The company currently has a market capitalization of $11.97 billion.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 5:30 pm

PLBY

PLBY Group shares are trading lower following disappointing Q2 financial results and a downgrade from Jefferies, which lowered its rating from Buy to Hold and reduced the price target from $1.5 to $0.7.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:26 pm